2018 Innovations and Initiatives in AI for the Pharmaceuticals Industry – ResearchAndMarkets.com

and Initiatives in AI for the Pharmaceuticals Industry”
has been added to ResearchAndMarkets.com’s offering.

This edition of the Future Tech TOE highlights the latest advancements
in AI technology arena that are empowering the pharma industry to
innovate across every level of the value chain.

The TOE provides an overview of the key trends, drivers, and challenges
pertaining to the adoption of AI in pharma, status of AI in the
pharmaceutical industry, key industry initiatives and funding landscape,
major partnerships in the space, key innovations related to drug
repositioning, drug discovery and clinical trial management. The study
also offers analysis of patenting trends revolving around various
geographics under the technology and key spending of top Pharma
companies toward AI projects.

The Future Tech TechVision Opportunity Engine (TOE) captures emerging
innovations in research and development, or profile existing
technologies which have seen a resurgence in terms of new markets and
applications. It usually provides a technology overview, drivers,
challenges, research and development, analyst insights and key patent
information. In some cases, technology convergence scenarios and future
growth opportunities are outlined.

It covers innovations and technologies in a variety of industry spaces
including manufacturing, sensors, electronics, information and
communications technologies, networks, lighting technologies,
healthcare, medical devices, materials and coatings, and developments in
the energy sector that contribute toward a sustainable and greener world.

Key Topics Covered

Artificial Intelligence – Overview and its Impact on Pharma

  • Trends in Artificial Intelligence Transforming the Global Healthcare
  • Key Drivers and Challenges for the Adoption of AI in the
    Pharmaceutical Industry
  • Status of Artificial Intelligence in the Pharmaceutical Industry
  • Artificial Intelligence Initiatives and Funding Landscape
  • Major Partnership and Collaboration of AI Companies with
    Pharmaceutical Companies
  • Key Innovations Across AI for Pharmaceutical Industries
  • Artificial Intelligence Technologies for Knowledge Synthesis and Drug
  • Artificial Intelligence Technologies for Drug Discovery
  • Artificial Intelligence for Clinical Trials Management
  • Speculated Spending of Top Pharma Companies on AI

Key Patents

  • Recent US Patents Related to AI-based Clinical Trials
  • Recent WIPO Patents Related to Identification of Biomarkers

Key Contacts

  • List of Contacts

For more information about this report visit https://www.researchandmarkets.com/research/gx2q9l/2018_innovations?w=4


Laura Wood, Senior Manager
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
For GMT Office Hours Call +353-1-416-8900
Topics: Pharmaceuticals,